11-36492236-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004620.4(TRAF6):​c.756+315G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0927 in 152,262 control chromosomes in the GnomAD database, including 715 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.093 ( 715 hom., cov: 32)

Consequence

TRAF6
NM_004620.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.42

Publications

15 publications found
Variant links:
Genes affected
TRAF6 (HGNC:12036): (TNF receptor associated factor 6) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]
TRAF6 Gene-Disease associations (from GenCC):
  • autosomal dominant hypohidrotic ectodermal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.12 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRAF6NM_004620.4 linkc.756+315G>A intron_variant Intron 6 of 6 ENST00000526995.6 NP_004611.1 Q9Y4K3
TRAF6NM_145803.3 linkc.756+315G>A intron_variant Intron 7 of 7 NP_665802.1 Q9Y4K3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRAF6ENST00000526995.6 linkc.756+315G>A intron_variant Intron 6 of 6 1 NM_004620.4 ENSP00000433623.1 Q9Y4K3
TRAF6ENST00000348124.5 linkc.756+315G>A intron_variant Intron 7 of 7 1 ENSP00000337853.5 Q9Y4K3
TRAF6ENST00000529150.1 linkn.301+315G>A intron_variant Intron 3 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.0928
AC:
14113
AN:
152144
Hom.:
714
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0638
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0682
Gnomad ASJ
AF:
0.115
Gnomad EAS
AF:
0.0502
Gnomad SAS
AF:
0.129
Gnomad FIN
AF:
0.114
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.113
Gnomad OTH
AF:
0.0951
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0927
AC:
14111
AN:
152262
Hom.:
715
Cov.:
32
AF XY:
0.0915
AC XY:
6816
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0636
AC:
2645
AN:
41562
American (AMR)
AF:
0.0680
AC:
1040
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.115
AC:
400
AN:
3470
East Asian (EAS)
AF:
0.0503
AC:
261
AN:
5184
South Asian (SAS)
AF:
0.128
AC:
619
AN:
4828
European-Finnish (FIN)
AF:
0.114
AC:
1212
AN:
10596
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.113
AC:
7679
AN:
68008
Other (OTH)
AF:
0.0951
AC:
201
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
647
1294
1942
2589
3236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.103
Hom.:
1546
Bravo
AF:
0.0858
Asia WGS
AF:
0.0890
AC:
311
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.41
DANN
Benign
0.45
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030472; hg19: chr11-36513786; API